预诊断血代谢物度和肝癌风险:一项针对中国男性的基于人口的研究

Zhuo-Ying Li1, Qiu-Ming Shen2, Jing Wang2

  • 1School of Public Health, Fudan University, Shanghai, 200032, China; State Key Laboratory of System Medicine for Cancer & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.

EBioMedicine
|February 2, 2024
PubMed
概括

这项研究量化了预诊断血中的186个向代谢物,以评估肝癌风险. 10个代谢物的代谢评分改善了肝癌的预测,表明潜在的风险预测因素.